< Back to latest news & events

Event

Webinar: A comparison of IP Practice in EU, US and JP for new medical use and method of treatment patenting

May 2022

Event date: 27th June 2022

HGF, Shiga and Wolf Greenfield and hosting a webinar to compare the IP Practice in EU, US and JP for new medical use and method of treatment patenting.

Our expert speakers will compare and contrast the opportunities and restrictions for patenting of new medical uses in the three jurisdictions with a case study that will consider new medical uses defined by new mechanism of actions; new dosage or treatment regimens; new medical uses defined by newly identified patient subgroup; and a new combination uses.

Date

27th June, 2022

Time

1pm (BST)

2pm (CEST)

9pm (JST)

8am (EST)

Speakers
  • Masato Iida, Shiga
  • Jeffrey D. Hsi, Wolf Greenfield
  • Laurence Gainey, HGF
  • Mike Nelson, HGF

Attendees

Michael
Nelson

Partner & European and UK Patent Attorney

Laurence
Gainey

Partner & European and UK Patent Attorney

Latest updates

A New Era for AI Patents in the UK: Supreme Court Aligns with the EPO

The UK Supreme Court has handed down its long-awaited judgment in Emotional Perception AI Limited (EPAI) vs Comptroller General of Patents, a decision which serves to significantly change the way …

Read article
Event - 23rd - 25th March 2026

HGF are Gold Sponsors of IPBC Europe 2026

HGF are proud sponsors of IPBC Europe 2026, taking place from 23-25 March 2026 at the Pullman Paris Montparnasse. Bringing together patent pioneers, in-house leaders and private practice specialists, IPBC …

Event details
Event - 8th - 11th February 2026

AUTM Meeting 2026

We are attending the AUTM Annual Meeting from 8–11 February, a flagship event bringing together technology transfer professionals from across the globe. AUTM connects innovators, universities, and industry leaders to …

Event details

The Antibody Series #5 | Epitope-defined antibody claims: when “binds to this epitope” becomes a risk of insufficiency

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews decisions made at the EPO; here, they reviewed an appeal in opposition proceedings after the revocation …

Read article

The Deity Shoes case: a question of design activity and the constraints on a designer’s freedom

The footwear brand Deity Shoes sought to enforce their Community Design rights, both registered and unregistered, against Mundorama Confort and Stay Design. However, Mundorama Confort and Stay Design found fault …

Read article

The Antibody Series #4 | pH points in antibody claims: when “same pH ” becomes an addition of matter

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they reviewed a revocation in opposition of a patent relating to …

Read article

The Antibody Series #3 | Antibody code names in claims: why “ACZ885” is not sufficient to define the antibody

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions. In this case, they examined a claim that identified an antibody by an internal …

Read article
Event - 3rd February 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details
See all updates